Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Oct. 29, 2016	Oct. 31, 2015	Nov. 01, 2014
Cash flows from operating activities:
Net income	$ 861,664	$ 696,878	$ 629,320
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	134,540	130,147	114,064
Amortization of intangibles	75,250	92,093	27,906
Stock-based compensation expense	63,421	68,919	50,812
Gains (Losses) on Extinguishment of Debt	3,290	0	0
Other non-cash activity	24,570	6,974	4,423
Excess tax benefit - stock options	(10,453)	(25,045)	(22,231)
Deferred income taxes	8,124	(52,214)	(77,711)
Change in operating assets and liabilities:
Accounts receivable	(9,392)	(71,198)	(36,460)
Inventories	38,221	(35,557)	24,642
Prepaid expenses and other current assets	(5,618)	2,861	(5,354)
Deferred compensation plan investments	(2,399)	(2,643)	(3,746)
Prepaid income tax	(4,315)	4,546	10,499
Accounts payable, deferred income and accrued liabilities	85,502	56,614	58,373
Deferred compensation plan liability	2,399	2,643	3,746
Income taxes payable	9,950	25,060	96,536
Other liabilities	6,141	7,720	(3,217)
Total adjustments	419,231	210,920	242,282
Net cash provided by operating activities	1,280,895	907,798	871,602
Cash flows from investing:
Purchases of short-term available-for-sale investments	(7,697,260)	(6,083,999)	(7,485,162)
Maturities of short-term available-for-sale investments	6,375,361	4,984,980	7,318,877
Sales of short-term available-for-sale investments	332,716	1,251,194	2,187,389
Additions to property, plant and equipment, net	(127,397)	(153,960)	(177,913)
Payments for acquisitions, net of cash acquired	(83,170)	(7,065)	(1,945,887)
(Increase) decrease in other assets	(18,520)	(8,275)	(12,055)
Net cash used for investing activities	(1,218,270)	(17,125)	(114,751)
Cash flows from financing activities:
Proceeds from long-term debt	1,235,331	0	1,995,398
Payments of Derivative Instruments	(33,430)	0	0
Payments of Financing Costs	(26,583)	0	0
Early Repayment of Senior Debt	(378,156)	0	0
Term Loan Repayments	0	0	(1,995,398)
Dividend payments to shareholders	(513,180)	(491,059)	(454,225)
Repurchase of common stock	(370,061)	(226,953)	(356,346)
Net proceeds from employee stock plans	61,496	122,631	200,114
Contingent consideration payment	(1,409)	(1,767)	(3,576)
(Decrease) Increase in other financing activities	(7,378)	500	15,192
Excess tax benefit - stock options	10,453	25,045	22,231
Net cash (used for) provided by financing activities	(22,917)	(571,603)	(576,610)
Effect of exchange rate changes on cash	(2,929)	(3,950)	(3,097)
Net (decrease) increase in cash and cash equivalents	36,779	315,120	177,144
Cash and cash equivalents at beginning of year	884,353	569,233	392,089
Cash and cash equivalents at end of year	$ 921,132	$ 884,353	$ 569,233